Hassan M. Eisa

405 total citations
35 papers, 322 citations indexed

About

Hassan M. Eisa is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Hassan M. Eisa has authored 35 papers receiving a total of 322 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 12 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Hassan M. Eisa's work include Synthesis and biological activity (19 papers), Synthesis and Characterization of Heterocyclic Compounds (16 papers) and Synthesis and Biological Evaluation (6 papers). Hassan M. Eisa is often cited by papers focused on Synthesis and biological activity (19 papers), Synthesis and Characterization of Heterocyclic Compounds (16 papers) and Synthesis and Biological Evaluation (6 papers). Hassan M. Eisa collaborates with scholars based in Egypt, United States and Switzerland. Hassan M. Eisa's co-authors include Khalid B. Selim, Abdelbasset A. Farahat, Morkos A. Henen, Fatma E. Goda, Mohamed A. Moustafa, Mohamed M. El‐Kerdawy, Magda N.A. Nasr, Shahenda M. El‐Messery, Serry A. A. El Bialy and David W. Boykin and has published in prestigious journals such as Scientific Reports, Molecules and Bioorganic & Medicinal Chemistry.

In The Last Decade

Hassan M. Eisa

33 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hassan M. Eisa Egypt 10 243 105 31 20 19 35 322
Nazar Trotsko Poland 13 369 1.5× 136 1.3× 20 0.6× 28 1.4× 40 2.1× 32 457
Ana M. Bruno Argentina 12 310 1.3× 127 1.2× 21 0.7× 40 2.0× 11 0.6× 27 408
Han-Bo Liu China 8 272 1.1× 213 2.0× 22 0.7× 16 0.8× 21 1.1× 18 408
Richard W. Heidebrecht United States 8 199 0.8× 83 0.8× 23 0.7× 9 0.5× 15 0.8× 10 298
Gültaze Çapan Türkiye 12 471 1.9× 108 1.0× 26 0.8× 34 1.7× 17 0.9× 24 541
Ola A. El‐Sayed Egypt 11 361 1.5× 60 0.6× 34 1.1× 17 0.8× 17 0.9× 21 397
Stéphanie Vandekerckhove Belgium 9 350 1.4× 90 0.9× 25 0.8× 13 0.7× 33 1.7× 9 422
Chandramohan Bathula India 10 149 0.6× 94 0.9× 19 0.6× 11 0.6× 12 0.6× 14 231
Garima Sumran India 12 468 1.9× 89 0.8× 28 0.9× 6 0.3× 14 0.7× 26 516
Bharvi Sharma India 9 299 1.2× 135 1.3× 61 2.0× 11 0.6× 18 0.9× 11 351

Countries citing papers authored by Hassan M. Eisa

Since Specialization
Citations

This map shows the geographic impact of Hassan M. Eisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan M. Eisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan M. Eisa more than expected).

Fields of papers citing papers by Hassan M. Eisa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan M. Eisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan M. Eisa. The network helps show where Hassan M. Eisa may publish in the future.

Co-authorship network of co-authors of Hassan M. Eisa

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan M. Eisa. A scholar is included among the top collaborators of Hassan M. Eisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan M. Eisa. Hassan M. Eisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Henen, Morkos A., et al.. (2022). New Benzimidazoles Targeting Breast Cancer: Synthesis, Pin1 Inhibition, 2D NMR Binding, and Computational Studies. Molecules. 27(16). 5245–5245. 9 indexed citations
3.
Abdel‐Aziz, Marwa M., et al.. (2022). Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity. Bioorganic Chemistry. 129. 106125–106125. 11 indexed citations
4.
5.
Mansour, Basem, et al.. (2021). Homology modelling, molecular dynamics simulation and docking evaluation of β-tubulin of Schistosoma mansoni. Biophysical Chemistry. 278. 106660–106660. 1 indexed citations
6.
Henen, Morkos A., et al.. (2020). Synthesis, state-of-the-art NMR-binding and molecular modeling study of new benzimidazole core derivatives as Pin1 inhibitors: Targeting breast cancer. Bioorganic & Medicinal Chemistry. 28(11). 115495–115495. 23 indexed citations
7.
Eisa, Hassan M., et al.. (2019). Design, Synthesis and Molecular Modeling of New 1,3,5-Triazine Derivatives as Anticancer Agents. Der pharma chemica. 11(5). 7–14. 4 indexed citations
8.
Selim, Khalid B., et al.. (2019). Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study. Bioorganic Chemistry. 90. 103076–103076. 31 indexed citations
9.
Eisa, Hassan M., et al.. (2015). Molecular modeling and synthesis of new 1,5-diphenylpyrazoles as breast cancer cell growth inhibitors. Heterocyclic Communications. 21(6). 367–375. 5 indexed citations
10.
Farahat, Abdelbasset A., Arvind Kumar, Fatma E. Goda, et al.. (2011). Exploration of larger central ring linkers in furamidine analogues: Synthesis and evaluation of their DNA binding, antiparasitic and fluorescence properties. Bioorganic & Medicinal Chemistry. 19(7). 2156–2167. 33 indexed citations
11.
Eisa, Hassan M., et al.. (2010). Synthesis and antimicrobial activity of certain benzimidazole and fused benzimidazole derivatives. Indian Journal of Chemistry Section B-organic Chemistry Including Medicinal Chemistry. 49(11). 1515–1525. 11 indexed citations
12.
Farahat, Abdelbasset A., et al.. (2010). Bichalcophenes: A concise synthesis of formyl ester‐ and cyano ester‐substituted bithiophenes, bifurans, and furanothiophenes. Journal of Heterocyclic Chemistry. 47(1). 167–170. 7 indexed citations
13.
Farahat, Abdelbasset A., Arvind Kumar, Martial Say, et al.. (2009). Synthesis, DNA binding, fluorescence measurements and antiparasitic activity of DAPI related diamidines. Bioorganic & Medicinal Chemistry. 18(2). 557–566. 28 indexed citations
14.
Moustafa, Mohamed A. & Hassan M. Eisa. (1992). Synthesis and Antimicrobial Activity of 3‐(Substituted‐phenyl)‐sydnones. Archiv der Pharmazie. 325(7). 397–401. 13 indexed citations
15.
Moustafa, Mohamed A., et al.. (1991). Synthesis of 1‐phenyi‐1H‐tetrazolo[4,5‐d]tetrazole and 5‐aryl‐1‐(4‐bromophenyl)‐1,2,4‐triazolo[4,3‐d]tetrazoles. Journal of the Chinese Chemical Society. 38(2). 199–201. 5 indexed citations
16.
Moustafa, Mohamed A., Hassan M. Eisa, Ali A. El‐Emam, & Ammal M. Metwally. (1990). Synthesis of certain uracil-6-yl or tetrazol-5-ylpyrazolin-5-one and pyrazole derivatives as potential anti-inflammatory agents. Archives of Pharmacal Research. 13(2). 204–206. 3 indexed citations
17.
El‐Kerdawy, Mohamed M., et al.. (1990). Synthesis of certain mercapto-and aminopyrimidine derivatives as potential antimicrobial agents. Archives of Pharmacal Research. 13(2). 142–146. 2 indexed citations
18.
El‐Kerdawy, Mohamed M., et al.. (1989). Synthesis and Some Chemical Behaviour of Certain Substituted Thiosemicarbazides. Journal of the Chinese Chemical Society. 36(4). 347–351. 2 indexed citations
19.
Eisa, Hassan M., et al.. (1989). Some nucleophilic substitutions in 2,4-and 2,4,8-trichloro-pyrido [3,2-d] pyrimidines. Archives of Pharmacal Research. 12(1). 8–11. 1 indexed citations
20.
El‐Emam, Ali A., Mohamed A. Moustafa, Hassan M. Eisa, & Mohamed M. El‐Kerdawy. (1986). Novel Antimicrobial Agents Obtained by Addition of Maleimide Derivatives to Thenaldehyde Azines or Schiff's Bases. Heterocycles. 24(4). 1025–1025. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nazar Trotsko Breakdown of academic impact, for papers by Ana M. Bruno Breakdown of academic impact, for papers by Han-Bo Liu Breakdown of academic impact, for papers by Richard W. Heidebrecht Breakdown of academic impact, for papers by Gültaze Çapan Breakdown of academic impact, for papers by Ola A. El‐Sayed Breakdown of academic impact, for papers by Stéphanie Vandekerckhove Breakdown of academic impact, for papers by Chandramohan Bathula Breakdown of academic impact, for papers by Garima Sumran Breakdown of academic impact, for papers by Bharvi Sharma
Rankless by CCL
2026